ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Ginder To direct Massey Cancer Center; UAB Receives $1 Million for Genetics Chair

August 15, 1997

Moses, Wattenberg Lead AACR; NCI Budget Cut By $4.8 Mil. For Shannon Awards Contribution

May 24, 1991

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982

DCPC Advisors Okay New Program Project Grants In Prevention

January 27, 1995

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

October 5, 2012

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

May 8, 1987